All these findings revealed that, as occurs in other organs, Nrf2/ARE signaling acts both directly and indirectly (manly cooperating with TGF-β/Smad pathway) to reduce inflammatory and fibrotic processes, and could be a novel effective therapeutic target in IBD [21,73,75,90] (Figure 2). This evidence concerns the gene NFE2L2 and inflammatory bowel disease.